Add Yahoo as a preferred source to see more of our stories on Google. If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that ...

You might think a biotech company that created a new vaccine, using novel tech like mRNA-based therapeutics, in record time to help the world fight a historic pandemic like COVID-19 would still be ...

Lipid nanoparticles, such as the one shown in this illustration, are used as vehicles to deliver mRNA-based vaccines. The U.S. Department of Health and Human Services announced on Tuesday that it will ...

The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel ...

New research from the University of Pittsburgh could help scientists develop the next generation of mRNA vaccines to be more effective and less expensive to produce. A study published this week in NPJ ...

COVID vaccine technology could help reduce disabilities in people caused by injuries from snakebites. Researchers at the University of Reading, England, found that the same mRNA tech used in ...

As the buzz builds around messenger RNA (mRNA) technology’s use for two leading COVID-19 candidates, manufacturers and regulatory professionals are facing facts: This is not simple technology. Complex ...

In the field of COVID-19 research, attention has turned to a critical aspect: the prion region on the surface spike proteins of the virus and its implications, especially in the context of mRNA ...

An mRNA therapy efficaciously corrected—in a mouse model—altered glutathione metabolism, offering a prospective avenue for treating argininosuccinic aciduria (ASA), an inherited metabolic disorder.

If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.